← Viking Therapeutics

What podcasts say about Viking Therapeutics

Every statement, with the speaker, the exact quote and the moment it was said.

What experts have said about Viking Therapeutics

6 statements · 5 positive · 1 negative

  1. Matthew CloutierNegativeOct 10, 2026· Breaking Biotech

    Viking is not among Matthew’s leading candidates for Lilly acquisition.

    “it doesn't seem like Viking would be on my high list”

    Listen at 11:37

    Open the episode · 118 - End of Week Wrap up - Oct 9, 2026
  2. Judy LeGrouxPositiveSep 22, 2026· Stock Movers

    Viking’s results are an optimistic sign for GLP-1 weight-loss maintenance.

    “Viking Therapeutics results are really an optimistic sign for that. particular process.”

    Listen at 1:26

    Open the episode · Viking Soars; On Holding Climbs; Quest Diagnostics Drops
  3. Judy LagrouPositiveSep 22, 2026· Stock Movers

    Viking Therapeutics’ results signal optimism for obesity-drug weight-loss maintenance.

    “Viking Therapeutics results are really an optimistic sign for that particular process.”

    Listen at 1:28

    Open the episode · Viking Soars; On Holding Climbs; Quest Diagnostics Drops
  4. Romaine BostickPositiveSep 22, 2026· Stock Movers

    Viking Therapeutics’ drug produced 22% weight loss over 33 weeks in a maintenance study.

    “this drug led to a 22% weight loss over 33 weeks in what they call a maintenance study”

    Listen at 3:17

    Open the episode · Alibaba and ON Rise; Viking Therapeutics Surges
  5. Romaine BostickPositiveSep 22, 2026· Stock Movers

    Viking Therapeutics’ drug could compete with Eli Lilly and Novo Nordisk.

    “it could be a contender to Eli Lilly and Novo Nordisk”

    Listen at 3:24

    Open the episode · Alibaba and ON Rise; Viking Therapeutics Surges
  6. Jim CramerPositiveNov 5, 2025· Mad Money w/ Jim Cramer

    Viking Therapeutics would likely receive a takeover bid.

    “I think that Viking would have gotten a bid if it didn't get it yet.”

    Listen at 36:24

    Open the episode · Mad Money w/ Jim Cramer 11/4/25

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.